Tharimmune Inc’s recently made public that its CEO MILBY RANDY acquired Company’s shares for reported $9752.0 on Dec 19 ’24. In the deal valued at $2.12 per share,4,600 shares were bought. As a result of this transaction, MILBY RANDY now holds 17,534 shares worth roughly $26125.66.
Then, Appajosyula Sireesh bought 5,000 shares, generating $10,096 in total proceeds. Upon buying the shares at $2.02, the Chief Operating Officer now owns 10,758 shares.
Before that, MILBY RANDY bought 2,500 shares. Tharimmune Inc shares valued at $5,221 were divested by the CEO at a price of $2.09 per share. As a result of the transaction, MILBY RANDY now holds 12,934 shares, worth roughly $19271.66.
Price Performance Review of THAR
On Tuesday, Tharimmune Inc [NASDAQ:THAR] saw its stock jump 2.76% to $1.49. Over the last five days, the stock has gained 5.67%. Tharimmune Inc shares have fallen nearly -26.60% since the year began. Nevertheless, the stocks have fallen -74.19% over the past one year. While a 52-week high of $7.46 was reached on 01/08/25, a 52-week low of $1.35 was recorded on 03/04/25. SMA at 50 days reached $1.9441, while 200 days put it at $2.7595.
Levels Of Support And Resistance For THAR Stock
The 24-hour chart illustrates a support level at 1.3500, which if violated will result in even more drops to 1.2100. On the upside, there is a resistance level at 1.5600. A further resistance level may holdings at 1.6300. The Relative Strength Index (RSI) on the 14-day chart is 32.61, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.2364, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.66%. Stochastics %K at 19.83% indicates the stock is a buying.
